Among the many thousands of proteins in the cell, some are essential players while some are "hangers-on." The neuronal protein syntaxin is essential. Without it, you die. A more recently discovered protein called tomosyn hangs on, or binds, to syntaxin. Its Japanese discoverers named it tomosyn by combining tomo -- "friend" in Japanese -- with "syn" for syntaxin, to mean "friend of syntaxin."
Now a U.S.-based research team reports this friendly protein appears to play a key role in regulating the synaptic release of neurotransmitter chemicals, which suggests that it may also play a role in learning and memory.
Better understanding of the neurological function of this protein may lead to a better understanding of how synapses get stronger or weaker, and how that, in turn, affects memory formation and loss, says Janet Richmond, associate professor of biological sciences at the University of Illinois at Chicago.
"It's amazing we remember things from as far back as our early childhood with the constant protein turnover going on in our brains," said Richmond. "So understanding how proteins function to control synaptic strength is really important."
Richmond and her colleagues used the soil nematode worm Caenorhabditis elegans to study the function of tomosyn using a recording technique she developed to understand how synaptic proteins affect release of neurotransmitters at the nerve cell junctions. The lab's ability to study synaptic transmission was recently improved with the addition of high pressure freeze electron microscopy and immuno-gold staining, which together provide a clearer picture of where neurotransmitter-containing synaptic vesicles and proteins cluster.
Mutant worms lacking tomosyn were compared to normal worms to determine what effect, if any, the protein had on neuronal transmission. The observed effect is substantial -- the protein helps put a limit on the number of synaptic vesicles that become competent to fuse at synapses, thereby regulating the amount of neurotransmitter released.
"If you remove tomosyn, you get exuberant neurotransmitter release," said Richmond. "This suggests tomosyn is a negative regulator of release. In other words, it dampens down the system, regulating the efficiency and strength of the synapse."
Because the nematode C. elegans uses proteins in its nervous system comparable to those in humans, Richmond suspects that forthcoming experiments involving tomosyn in mammals such as laboratory mice will show similar results.
Source: University of Illinois at Chicago
Related stories:
Fatal protein interactions may explain neurological diseases
In a collaborative study at the University of California, San Diego, investigators from neurosciences, chemistry and medicine, as well as the San Diego Supercomputer Center (SDSC) have investigated how proteins involved in neurodegenerative diseases such as Alzheimer's and Parkinson's disease interact to form unique complexes. Their findings explain why Alzheimer's patients might develop Parkinson's, and vice versa. The new and unique molecular structures they discovered can now be used to model and develop new drugs for these devastating neurological diseases. Their findings will be published in the September 3 issue of
Public Library of Science (PLoS) ONE on September 4, 2008.
The first autism disease genes
The autistic disorder was first described, more than sixty years ago, by Dr. Leo Kanner of the Johns Hopkins Hospital (USA), who created the new label 'early infantile autism'. At the same time an Austrian scientist, Dr. Hans Asperger, described a milder form of the disorder that became known as Asperger Syndrome, characterised by higher cognitive abilities and more normal language function. Today, both disorders are classified in the continuum of 'Pervasive Developmental Disorders' (PDD), more often referred to as Autism Spectrum Disorders (ASD).
Cocaine: How addiction develops
Permanent drug seeking and relapse after renewed drug administration are typical behavioral patterns of addiction. Molecular changes at the connection points in the brain's reward center are directly responsible for this. This finding was published by a research team from the Institute of Mental Health (ZI) in Mannheim, the German Cancer Research Center (DKFZ) in Heidelberg and the University of Geneva, Switzerland, in the latest issue of
Neuron. The results provide researchers with new approaches in the medical treatment of drug addiction.
Multi-tasking molecule holds key to allergic reactions
As the summer approaches most of us rejoice, reach for the sunscreen and head outdoors. But an ever-growing number of people reach for tissue instead as pollen leaves eyes watering, noses running and spirits dwindling. Hay fever is just one of a host of hypersensitivity allergic diseases that cause suffering worldwide and others, such as severe reactions to bee stings or eating peanuts, can be more serious and even fatal.
Improved estrogen reception may sharpen fuzzy memory
Estrogen treatments may sharpen mental performance in women with certain medical conditions, but University of Florida researchers suggest that recharging a naturally occurring estrogen receptor in the brain may also clear cognitive cobwebs.
Location, location, location
Neuroscientists at Georgetown University Medical Center have solved a mystery that lies at the heart of human learning, and they say the solution may help explain some forms of mental retardation as well as provide clues to overall brain functioning.
Ionophore reverses Alzheimer's within days in mouse models
Scientists report a remarkable improvement in Alzheimer's transgenic mice following treatment with a new drug. The study, published by Cell Press in the July 10th issue of the journal
Neuron, provides the first demonstration that an ionophore, a compound that transports metal ions across cell membranes, can elicit rapid and pronounced improvement in neuropathology and cognitive function in mouse models of Alzheimer's Disease (AD).
Protein on 'speed' linked to ADHD
A genetic change in the dopamine transporter – one of the brain's dopamine-handling proteins – makes it behave as if amphetamine is present and "run backward," Vanderbilt University Medical Center investigators report this week in
The Journal of Neuroscience.